| Anticoagulant Reagents |
| Product |
Product # |
| Heparin sodium salt bovine intestinal mucosa ³140 USP units/mg |
H0777 |
| Heparin sodium salt from porcine intestinal mucosa Grade I-A ~170 USP units/mg |
H3393 |
| Citrate-phosphate-dextrose solution with adenine |
C4431 |
| Citrate-phosphate-dextrose solution aseptically filled |
C7165 |
| Citrate-dextrose solution (ACD) sterile-filtered |
C3821 |
| Ethylenediaminetetraacetic acid disodium salt solution 2% solution |
285-4 |
| Polyanetholesulfonic acid sodium salt powder |
P2008 |
| Sodium citrate tribasic solution 4 % (w/v) |
S5770 |
| Factor V |
back to top |
| Product |
Product # |
| Activator |
|
| Factor V Activating Enzyme Russell's viper venom lyophilized powder 20 units/mg protein (E1%, 10.0 at 280 nm) |
F3380 |
| Factor VIII |
back to top |
| Product |
Product # |
| Inhibitor |
|
| Acetyl-Ala-Leu-Cys-Asp-Asp-Pro-Arg-Val-Asp-Arg-Trp-Tyr-Cys-Gln-Phe-Val-Glu-Gly-NH2 [Disulfide bridge: 3-13] ³95% (HPLC) |
A0472 |
| Factor IX |
back to top |
| Product |
Product # |
| Factor IX human, lyophilized powder |
F0650 |
| Factor X |
back to top |
| Product |
Product # |
| Enzyme |
|
| Factor X bovine plasma, buffered aqueous solution ~80 units/mg protein (E1%, 12.4 at 280 nm) |
F4003 |
| Factor X Activated (Xa) bovine plasma, lyophilized powder |
F2027 |
| Inhibitor |
|
| 3,4-Dichloroisocoumarin |
D7910 |
| a2-Antiplasmin from human plasma lyophilized powder ³5 inhibitor U/mg protein |
A0914 |
| Antithrombin III from bovine plasma, lyophilized powder 200-400 units/mg protein (E1%/280 = 6.5) |
A9141 |
| Antithrombin III from human plasma ³95% (SDS-PAGE) lyophilized powder |
A2221 |
| Antithrombin III from rat plasma, lyophilized powder >200 units/mg protein (E1%/280 = 6.5) |
A6397 |
| Diisopropyl fluorophosphate |
D0879 |
| Ecotin recombinant, expressed in Escherichia coli ³90% (SDS-PAGE) essentially salt-free, lyophilized powder ³2000 units/mg protein |
E1398 |
| Substrate |
|
| Factor Xa chromogenic substrate solid |
F3301 |
| Factor XII |
back to top |
| Product |
Product # |
| Inhibitor |
|
| Esterase inhibitor C-1 from human plasma, >95% (SDS-PAGE) buffered aqueous solution |
E0518 |
| Fibrin/Fibrinogen |
back to top |
| Product |
Product # |
| Fibrin |
|
| Fibrin from human plasma |
F5386 |
| Fibrinogen |
|
| Fibrinogen from bovine plasma Type IV |
F4753 |
| Fibrinogen from bovine plasma Type I-S powder |
F8630 |
| Fibrinogen from cat plasma |
F8513 |
| Fibrinogen from canine plasma |
F7128 |
| Fibrinogen from human plasma Type I |
F3879 |
| Fibrinogen from human plasma Type III |
F4129 |
| Fibrinogen from human plasma, Essentially plasmin(ogen) free powder |
F4883 |
| Fibrinogen from murine plasma |
F4385 |
| Fibrinogen from porcine plasma |
F2629 |
| Fibrinogen from rat plasma |
F6755 |
| Fibrinogen from sheep plasma |
F9754 |
| Inhibitor |
|
| N-Acetyl-Pen-Arg-Gly-Asp-Cys [Disulfide bridge: 1-5] ³97% (HPLC) |
A5582 |
| Related Peptides |
|
| Gly-Pro-Arg-Pro ³97% (HPLC) |
G1895 |
| Gly-Pro-Arg-Pro amide ³97% (HPLC) |
G5779 |
| Fibrinogen-binding Inhibitor Peptide ³97% (HPLC) |
F9145 |
| Fibrinopeptide A ³97% (HPLC) |
F3254 |
| Fibrinopeptide B Human ³97% (HPLC) |
F3379 |
| [Glu1]-Fibrinopeptide B human ³90% (HPLC) |
F3261 |
| Kallikrein |
back to top |
| Product |
Product # |
| Enzyme |
|
| Kallikrein from porcine pancreas ³40 units/mg solid |
K3627 |
| Kininogen |
back to top |
| Product |
Product # |
| Kininogen High Molecular Weight, Two Chain from human plasma lyophilized powder |
K1632 |
| Kininogen, low molecular weight from human plasma >95% (SDS-PAGE) lyophilized powder |
K3628 |
| Plasmin/Plasminogen |
back to top |
| Product |
Product # |
| Activator |
|
| Glu-Gly-Arg chloromethyl ketone ³90% (HPLC) powder |
G2917 |
| Streptokinase β-hemolytic Streptococcus (Lancefield Group C), lyophilized powder |
S3134 |
| Streptokinase β-hemolytic Streptococcus (Lancefield Group C), buffered aqueous solution ~100,000 units/mg protein |
S8026 |
| Tissue plasminogen activator chromogenic substrate ³95% (HPLC) solid |
T2943 |
| Tissue Plasminogen Activator |
T4825 |
| Inhibitor |
|
| a2-Antiplasmin from human plasma lyophilized powder ³5 inhibitor U/mg protein |
A0914 |
| Aprotinin bovine lung, lyophilized powder 3-7 TIU/mg solid |
A1153 |
| 3,4-Dichloroisocoumarin |
D7910 |
| 4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride ~97% |
A8456 |
| 6-Aminohexanoic acid, >99% (titration) powder |
A2504 |
| 6-Aminohexanoic acid, SigmaUltra >99% |
A7824 |
| α2-Macroglobulin from human plasma, >98% (SDS-PAGE) lyophilized powder |
M6159 |
| α2-Antiplasmin from human plasma, lyophilized powder >5 inhibitor U/mg protein |
A0914 |
| Antipain dihydrochloride microbial source |
A6191 |
| Antithrombin III from bovine plasma, lyophilized powder 200-400 units/mg protein (E1%/280 = 6.5) |
A9141 |
| Antithrombin III from human plasma ³95% (SDS-PAGE) lyophilized powder |
A2221 |
| Aprotinin bovine lung, lyophilized powder 3-7 TIU/mg solid |
A1153 |
| Bdellin from leeches lyophilized powder >0.1 IU/mg protein (E280) |
B3906 |
| Diisopropyl fluorophosphate |
D0879 |
| Elastatinal microbial ~50% |
E0881 |
| Esterase inhibitor C-1 from human plasma, >90% (SDS-PAGE) |
C2412 |
| Esterase inhibitor C-1 from human plasma, >95% (SDS-PAGE) buffered aqueous solution |
E0518 |
| Gabexate mesylate solid |
G2417 |
| Leupeptin trifluoroacetate salt, >90% (HPLC) microbial |
L2023 |
| Phenylmethanesulfonyl fluoride, >99% (GC) |
P7626 |
| Urinary Trypsin Inhibitor Fragment, >95% (HPLC) |
U4751 |
| Plasmin |
|
| Plasmin from human plasma |
P1867 |
| Plasminogen |
|
| Plasminogen from rabbit plasma, lyophilized powder 4-10 units/mg protein |
P2284 |
| Plasminogen bovine plasma, not suitable for streptokinase determination by clot formation procedure lyophilized powder 3-5 units/mg protein |
P9156 |
| Plasminogen from human plasma, suitable for streptokinase determination by clot formation procedure lyophilized powder >2 units/mg protein |
P5661 |
| Plasminogen from human plasma, not suitable for streptokinase determination by clot formation procedure lyophilized powder >2 units/mg protein |
P7397 |
| Receptor |
|
| Urokinase-type Plasminogen Activator Receptor-1/Fc Chimera from mouse, recombinant, expressed in mouse NSO cells >90% (SDS-PAGE) lyophilized powder |
U9757 |
| Substrate |
|
| Boc-Val-Leu-Lys-7-amido-4-methylcoumarin |
B1136 |
| D-Ala-Leu-Lys-7-amido-4-methylcoumarin 95% (HPLC) |
A8171 |
| D-Ile-Phe-Lys p-nitroanilide, >95% (HPLC) |
I6886 |
| D-Val-Leu-Lys 4-nitroanilide dihydrochloride |
V0882 |
| Gly-Arg-p-nitroanilide dihydrochloride |
G8148 |
| N-(p-Tosyl)-Gly-Pro-Lys 4-nitroanilide acetate salt |
T6140 |
| Z-Ala-Ala-Lys 4-methoxy-b-naphthylamide formate salt |
C2147 |
| D-Val-Leu-Lys 4-methoxy-2-naphthylamide solid |
V3263 |
| D-Val-Leu-Lys 7-amido-4-methylcoumarin ³99% (HPLC) lyophilized powder |
V3138 |
| D-Val-Leu-Lys 7-amido-4-trifluoromethylcoumarin lyophilized powder |
V3013 |
| D-Val-Phe-Lys p-Nitroanilide dihydrochloride ³97% (HPLC) |
V6884 |
| pGlu-Gly-Arg-7-amido-4-trifluoromethylcoumarin ³95% (HPLC) lyophilized powder |
P5615 |
| Tissue plasminogen activator chromogenic substrate ³95% (HPLC) solid |
T2943 |
| Gly-Arg-p-nitroanilide dihydrochloride |
G8148 |
| N-Benzoyl-Val-Gly-Arg p-nitroanilide hydrochloride |
B4758 |
| N-Glutaryl-Gly-Arg-7-amido-4-methylcoumarin hydrochloride |
G2386 |
| pGlu-Gly-Arg-7-amido-4-trifluoromethylcoumarin ³95% (HPLC) lyophilized powder |
P5615 |
| Z-Gly-Gly-Arg 4-methoxy-b-naphthylamide hydrochloride |
C5770 |
| Z-Gly-Gly-Arg 7-amido-4-methylcoumarin hydrochloride |
C9396 |
| Platelet Activators |
back to top |
| Product |
Product # |
| Activator |
|
| Ristomycin monosulfate >90% as ristocetin A (balance primarily Ristocetin B) |
R7752 |
| Protein C |
back to top |
| Product |
Product # |
| Enzyme |
|
| Protein C human, lyophilized powder |
P2562 |
| Protein C human plasma, Activated >90% (SDS-PAGE) lyophilized powder |
P2200 |
| Thrombin/Prothrombin (Factor II) |
back to top |
| Product |
Product # |
| Activator |
|
| Ecarin from Echis carinatus venom |
E0504 |
| Enzyme |
|
| Factor II human plasma lyophilized powder 5-20 units/mg protein (E1%, 15.5 at 280 nm) |
F5132 |
| Agkistrodon contortrix thrombin-like enzyme, lyophilized powder |
A8766 |
| Ancrod from Agkistrodon rhodostoma (Malayan pit viper) venom lyophilized powder ³200 NIH units/mg protein (E1%, 14.8 at 280 nm) |
A5042 |
| Thrombin bovine plasma, lyophilized powder 50-150 NIH units/mg protein |
T3399 |
| Thrombin bovine plasma, lyophilized powder 175-350 NIH units/mg protein (biuret) |
T4265 |
| Thrombin bovine plasma, lyophilized powder 40-165 NIH units/mg protein (biuret) |
T4648 |
| Thrombin bovine plasma lyophilized powder ³2,000 NIH units/mg protein (E1%/280 = 19.5) |
T7513 |
| Thrombin bovine plasma, >125 NIH units/mg protein (biuret) |
T9000 |
| Thrombin bovine plasma lyophilized powder ³700 NIH units/mg protein (Bradford) |
T9681 |
| Thrombin from human plasma, lyophilized powder 50-300 NIH units/mg protein |
T0553 |
| Thrombin from human plasma lyophilized powder >2800 NIH units/mg protein (E1%/280 = 18.3, 18.3 at 280 nm) |
T1063 |
| Thrombin from human plasma, cell culture tested lyophilized powder ~1,000 NIH units/mg protein (E1%, 18.3 at 280 nm) |
T4393 |
| Thrombin from human plasma lyophilized powder ³2,000 NIH units/mg protein (E1%, 18.3 at 280 nm) |
T6884 |
| Thrombin from human plasma lyophilized powder ~1,000 NIH units/mg protein (E1%, 18.3 at 280 nm) |
T7009 |
| Thrombin from human plasma, lyophilized powder Suitable for routine use in the thrombin time test |
T8885 |
| Thrombin from human plasma, lyophilized powder Suitable for routine use in the thrombin time test |
T9135 |
| Thrombin from human plasma lyophilized powder 50-300 NIH units/mg protein |
T9677 |
| Thrombin from murine plasma lyophilized powder ~1,000 NIH units/mg protein (biuret) |
T8397 |
| Inhibitor |
|
| [Lys47]Hirudin (HV2), leech, recombinant, expressed in Saccharomyces cerevisiae 7,000-14,000 ATU/mg protein (ATU = antithrombin units) |
H0393 |
| 3,4-Dichloroisocoumarin |
D7910 |
| 4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride, ~97% |
A8456 |
| a2-Antiplasmin from human plasma lyophilized powder ³5 inhibitor U/mg protein |
A0914 |
| Antipain dihydrochloride microbial source |
A6191 |
| Antithrombin III from bovine plasma, lyophilized powder 200-400 units/mg protein (E1%/280 = 6.5) |
A9141 |
| Antithrombin III from human plasma ³95% (SDS-PAGE) lyophilized powder |
A2221 |
| Antithrombin III from rat plasma, lyophilized powder >200 units/mg protein (E1%/280 = 6.5) |
A6397 |
| Diisopropyl fluorophosphate |
D0879 |
| D-Val-Leu-Lys-chloromethyl ketone ³90% (HPLC) white powder |
V3763 |
| Gabexate mesylate solid |
G2417 |
| Hirudin leeches ³1,500 ATU/mg protein (ATU = antithrombin units) |
H7016 |
| Hirudin leeches lyophilized powder 300-1,500 ATU/mg protein (ATU = antithrombin units) |
H7380 |
| Hirudin leeches lyophilized powder ³6,000 ATU/mg protein (ATU = antithrombin units) |
H9022 |
| [Tyr(SO3H)63]-Hirudin Fragment 54-65 ³95% (HPLC) |
H6894 |
| [Tyr(SO3H)63]-Hirudin Fragment 55-65 ³97% (HPLC) |
H8894 |
| Leupeptin trifluoroacetate salt, >90% (HPLC) microbial |
L2023 |
| Na-(2-Naphthalenesulfonylglycyl)-4-amidino-DL-phenylalaninepiperidide 0.1 µmole/mg solid (balance glycine) |
N8514 |
| N-Acetyl-eglin C recombinant, expressed in unspecified host |
E7888 |
| Nα-p-Tosyl-L-lysine chloromethyl ketone hydrochloride, >96% (TLC) powder |
T7254 |
| Phenylmethanesulfonyl fluoride, >99% (GC) |
P7626 |
| Antithrombin III from bovine plasma, lyophilized powder 200-400 units/mg protein (E1%/280 = 6.5) |
A9141 |
| Antithrombin III from human plasma ³95% (SDS-PAGE) lyophilized powder |
A2221 |
| Related Proteins |
|
| Protein Z human plasma liquid |
P7489 |
| Substrate |
|
| 4-Methylumbelliferyl 4-guanidinobenzoate hydrochloride hydrate crystalline |
M4149 |
| Boc-b-benzyl-Asp-Pro-Arg-7-amido-4-methylcoumarin hydrochloride ~95% |
B4028 |
| Boc-Val-Pro-Arg-7-amido-4-methylcoumarin hydrochloride |
B9385 |
| N-(p-Tosyl)-Gly-Pro-Arg p-nitroanilide acetate salt |
T1637 |
| N-Benzoyl-Phe-Val-Arg 4-methoxy-b-naphthylamide hydrochloride |
B1260 |
| N-Benzoyl-Phe-Val-Arg-p-nitroanilide hydrochloride |
B7632 |
| N-p-Tosyl-Gly-Pro-Arg 7-amido-4-methylcoumarin hydrochloride |
T0273 |
| Sar-Pro-Arg p-nitroanilide dihydrochloride |
S9009 |
| Thrombin generation chromogenic substrate ³90% (TLC) solid |
T3068 |
